Lovesac, Avidity Biosciences, Veritone, and Other Major Stocks Decline in Thursday's Pre-Market Trading
U.S. Stock Futures: U.S. stock futures are up, with Dow futures increasing by approximately 0.2% on Thursday morning.
Lovesac Co Performance: Lovesac Co's shares fell 13% in pre-market trading after reporting a second-quarter loss of 45 cents per share, which was better than expected, but the company lowered its FY2026 EPS guidance significantly.
Other Stocks Declining: Several other stocks also saw significant declines in pre-market trading, including Avidity Biosciences (down 20.1%) and Veritone, Inc. (down 18.7%), following announcements of stock offerings.
Market Overview: The overall market sentiment appears cautious, with multiple companies experiencing sharp declines in their stock prices amid earnings reports and new offerings.
Trade with 70% Backtested Accuracy
Analyst Views on VERI
About VERI
About the author

- Legal Investigation Launched: Bragar Eagel & Squire is investigating whether Veritone has violated federal securities laws, potentially affecting all investors and indicating serious issues with the company's governance and compliance.
- Financial Reporting Errors: On April 14, 2026, Veritone disclosed that its previously issued unaudited financial statements for Q3 and nine months of 2025 contained errors, resulting in a $2.48 million (8.53%) reduction in quarterly revenue, directly impacting investor confidence.
- Significant Stock Price Reaction: Following the announcement of financial errors, Veritone's stock price fell by $0.19 (8.33%) to close at $2.09 per share on April 15, 2026, reflecting market concerns about the company's financial health.
- Investor Rights Protection: Bragar Eagel & Squire encourages all affected investors to contact them to understand their legal rights and potential claims, demonstrating the firm's commitment to protecting investor interests.
- Uncertain Financial Results: On March 26, 2026, Veritone filed an 8-K with the SEC, projecting fourth-quarter 2025 revenues between $18.1 million and $30 million, as it was finalizing accounting determinations, which led to a 30% drop in share price to $1.84, indicating market concerns over financial transparency.
- Financial Statement Corrections: On April 14, 2026, Veritone disclosed that its previously issued unaudited financial statements for the third quarter and nine months ended September 30, 2025, were no longer reliable, citing five categories of errors that collectively reduced quarterly revenue by $2.48 million (8.53%), further raising investor concerns about corporate governance and causing an 8.3% decline in share price.
- Ongoing Legal Investigation: Kirby McInerney LLP is conducting an investigation on behalf of Veritone investors to assess potential violations of federal securities laws by the company and its senior management, and while no lawsuit has been filed yet, this process could impact the company's future legal liabilities and market trust.
- Investor Rights Protection: The law firm encourages investors who purchased Veritone securities to provide information to protect their rights during the investigation, highlighting the increasing demand for legal support amid uncertain financial conditions.
- Financial Reporting Errors: On April 14, 2026, Veritone disclosed that its unaudited financial statements as of September 30, 2025, contained errors, severely undermining investor trust and leading to a stock price drop.
- Legal Investigation Initiated: Holzer & Holzer, LLC is investigating whether Veritone violated federal securities laws, indicating potential legal liabilities for the company and further losses for investors.
- Investor Loss Alerts: Due to the financial statement errors, investors holding Veritone stock may have incurred losses, prompting Holzer & Holzer to seek affected investors for legal consultations, highlighting their commitment to protecting investor rights.
- Company Reputation Damage: This incident not only impacts Veritone's stock price but may also have long-term negative effects on its future financing and market trust, increasing operational risks in the capital markets.
- Financial Reporting Errors: On April 14, 2026, Veritone disclosed to the SEC that its previously issued unaudited financial statements for the three and nine months ended September 30, 2025, contained five categories of errors, collectively reducing quarterly revenue by $2.48 million (8.53%) to $26.63 million, severely impacting investor confidence.
- Stock Price Reaction: Following this announcement, Veritone's stock price fell by $0.19 per share, or 8.33%, closing at $2.09 on April 15, 2026, reflecting market concerns over the company's financial transparency.
- Legal Investigation Initiated: Pomerantz LLP is investigating Veritone and its executives to assess potential securities fraud or other unlawful business practices, which could lead to class action lawsuits and further exacerbate the company's legal risks.
- Investor Advisory: Pomerantz LLP advises affected investors to contact their attorneys, highlighting the firm's expertise in securities fraud cases and its commitment to seeking compensation for victims, demonstrating a strong focus on protecting investor rights.

New Job Distribution Platform: Veritone Inc. has launched a new job distribution platform aimed at enhancing employment opportunities in the UK.
Collaboration with UK Department: The platform has been adopted by the UK Department for Work and Pensions, indicating a significant partnership to improve job accessibility.
- Securities Fraud Investigation: Pomerantz LLP is investigating claims on behalf of Veritone, Inc. investors, focusing on whether the company and its executives engaged in securities fraud or other unlawful business practices, potentially exposing investors to significant losses.
- Financial Reporting Issues: On April 14, 2026, Veritone disclosed to the SEC that its previously issued unaudited financial statements for the three and nine months ended September 30, 2025 contained five categories of errors, resulting in a $2.48 million (8.53%) reduction in quarterly revenue, impacting the company's financial transparency.
- Stock Price Reaction: Following the disclosure of financial issues, Veritone's stock price fell by $0.19, or 8.33%, closing at $2.09 per share on April 15, 2026, reflecting market concerns regarding the company's financial health.
- Potential Legal Action Impact: Pomerantz LLP, recognized for its expertise in securities class actions, may provide legal support for affected investors, further exacerbating the trust crisis surrounding Veritone and potentially impacting its future financing capabilities.










